IMMP

MKT CAP:$84M

Immutep Limited

Market Cap

$84M

Healthcare·Biotechnology·🇦🇺 Australia·NASDAQ

Healthcare·Biotechnology·🇦🇺·NASDAQ

Stock Price

$0.57-$2.38 (-80.65%)

Apr 23, 2026

Company Details

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product ca...

CEO

Marc Voigt

IPO Date

Apr 19, 2012

Website

www.immutep.com

Key Metrics TTM

Revenue

$9M

+15.5% YoY

Net Income

-$42M

EPS (Diluted)

-$0.54

Free Cash Flow

-$61M

Revenue / Share

$0.06

Gross Margin

-443.8%

Operating Margin

-951.1%

Net Margin

-480.3%

FCF Margin

-687.9%

P/S

9.5x

P/E

—

Earnings Reports

FY 2025

Jun 30, 2025

$4M+31.3%EPS -$0.30

Q2 2025

Feb 27, 2025

$2MEPS -$0.11

FY 2024

Oct 22, 2024

$3M+9.6%EPS -$0.26

Q4 2024

Oct 22, 2024

$1MEPS -$0.13

FY 2023

Oct 24, 2023

$3M+1957.7%EPS -$0.31

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 11	$0	$0	-$5M
Q2 12	$542.7K	$500.9K	-$7M
Q2 13	$1M	-$4M	-$6M
Q4 13	$114.2K	-$5M	-$7M
Q2 14	$1M	-$3M	-$5M
Q4 14	$197.3K	-$4M	-$5M
Q2 15	$835.5K	-$3M	-$5M
Q4 15	$118.2K	-$3M	-$6M
Q2 17	$1M	-$799.4K	-$3M
Q2 18	$3M	-$292.9K	-$4M
Q4 18	$2M	-$2M	-$5M
Q2 19	$2M	-$4M	-$7M
Q4 19	$99.8K	-$6M	-$9M
Q2 20	$5M	-$3M	-$6M
Q4 24	$1M	-$14M	-$32M
Q2 25	$2M	-$16M	-$37M

Valuation

Quarter	P/S	P/E
Q4 11	201.7x	—
Q2 12	103.4x	—
Q2 13	254.0x	—
Q4 13	195.5x	—
Q2 14	51.5x	—
Q4 14	81.4x	—
Q2 15	42.5x	—
Q4 15	130.5x	—
Q2 17	77.9x	—
Q2 18	30.6x	—
Q4 18	41.3x	—
Q2 19	24.7x	—
Q4 19	33.6x	—
Q2 20	25.4x	—
Q4 24	35.5x	—
Q2 25	34.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 13	-$7M	-$7M
Q4 13	-$4M	-$5M
Q2 14	-$6M	-$6M
Q4 14	-$4M	-$4M
Q2 15	-$5M	-$5M
Q4 15	-$791.3K	-$792.5K
Q2 16	-$5M	-$5M
Q2 17	-$3M	-$3M
Q2 18	-$3M	-$3M
Q4 18	-$3M	-$3M
Q2 19	-$4M	-$4M
Q4 19	-$3M	-$3M
Q2 20	-$4M	-$4M
Q4 24	-$12M	-$13M
Q2 25	-$20M	-$20M
Q4 25	-$24M	-$24M

Capital Expenditures

Quarter	CapEx
Q2 13	$36.5K
Q4 13	$326.2K
Q2 14	$37.5K
Q4 14	$36.5K
Q2 15	$33.5K
Q4 15	$1.2K
Q2 16	$4.6K
Q2 17	$877
Q2 18	$3.9K
Q4 18	$4.6K
Q2 19	$12.3K
Q4 19	$12.1K
Q2 20	$10.8K
Q4 24	$332.9K
Q2 25	$8.2K
Q4 25	$24.5K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 11	—	+500.0%
Q2 12	+190.2%	+137.4%
Q2 13	+468.5%	+132.2%
Q4 13	—	+32.2%
Q2 14	—	+21.0%
Q4 14	-63.6%	-20.7%
Q2 15	-21.4%	-16.7%
Q4 15	+3.5%	-15.7%
Q2 17	-8.8%	-33.4%
Q2 18	+1433.5%	+20.4%
Q4 18	+123.6%	+16.8%
Q2 19	+1277.9%	+49.5%
Q4 19	-91.2%	+129.4%
Q2 20	+73.8%	+67.3%
Q4 24	-33.8%	+386.9%
Q2 25	+38.0%	+366.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 13	$0	0.0%
Q4 13	$135.3K	118.5%
Q2 14	$0	0.0%
Q4 14	$40.9K	20.7%
Q2 15	$0	0.0%
Q4 15	$931.5K	787.8%
Q2 16	$34M	—
Q2 17	$0	0.0%
Q2 18	$0	0.0%
Q4 18	$2M	86.5%
Q2 19	$0	0.0%
Q4 19	$1M	1131.8%
Q2 20	$559.9K	10.6%
Q4 24	$0	0.0%
Q2 25	$0	0.0%
Q4 25	$830.9K	—

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 11	$3M	$2M	—
Q2 12	$5M	$3M	—
Q2 13	—	$2M	—
Q4 13	$10M	$2M	—
Q2 14	—	$2M	—
Q4 14	$8M	$1M	—
Q2 15	—	$2M	—
Q4 15	$6M	$2M	—
Q2 17	—	$2M	—
Q2 18	—	$3M	—
Q4 18	$6M	$2M	—
Q2 19	—	$2M	—
Q4 19	$11M	$2M	$6M
Q2 20	—	$2M	$8M
Q4 24	$15M	$3M	—
Q2 25	$18M	$3M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 18	$17M	$0	$17M
Q2 19	$19M	$0	$19M
Q4 19	$12M	$0	$12M
Q2 20	$15M	$0	$15M
Q4 20	$19M	$0	$19M
Q2 21	$39M	$0	$39M
Q4 21	$43M	$0	$43M
Q2 22	$71M	$0	$71M
Q4 22	$57M	$0	$57M
Q2 23	$49M	$0	$49M
Q4 23	$88M	$0	$88M
Q2 24	$74M	$0	$74M
Q4 24	$116M	$14M	$130M
Q2 25	$53M	$61M	$114M
Q4 25	$48M	$44M	$93M
Q2 26	$52M	$19M	$71M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 11	43M	0.0%	0.0%
Q2 12	43M	0.0%	0.0%
Q2 13	43M	0.0%	0.0%
Q4 13	43M	0.0%	0.0%
Q2 14	43M	0.0%	0.0%
Q4 14	43M	0.0%	0.0%
Q2 15	43M	0.0%	0.0%
Q4 15	43M	0.0%	0.0%
Q2 17	43M	0.0%	0.0%
Q2 18	43M	0.0%	0.0%
Q4 18	43M	0.0%	0.0%
Q2 19	43M	0.0%	0.0%
Q4 19	34M	-19.8%	-19.8%
Q2 20	39M	+13.5%	-9.0%
Q4 24	122M	+213.0%	+184.9%
Q2 25	145M	+19.5%	+240.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 11	—	—
Q2 12	—	—
Q2 13	$40.9K	26
Q4 13	$3.8K	30
Q2 14	$41.5K	30
Q4 14	$6.4K	31
Q2 15	$27.0K	31
Q4 15	$5.6K	21
Q2 17	$51.6K	22
Q2 18	$178.0K	17
Q4 18	$98.3K	19
Q2 19	$85.8K	19
Q4 19	$4.2K	24
Q2 20	$219.2K	24
Q4 24	$28.1K	44
Q2 25	$51.1K	44

Revenue / Employee